898128-02-4Relevant academic research and scientific papers
LIPOXYGENASE INHIBITORS
-
Paragraph 00404, (2021/07/02)
Various embodiments of the present disclosure are directed to compounds having Formula I, Formula II, Formula IIA, Formula III, Formula IIIA, Formula IIIB, and/or pharmaceutically acceptable salts thereof. The compounds can be suitable for inhibiting lipoxygenases and/or treating associated diseases. In some embodiments, subject compounds are used to prepare a composition that is effective in treating neurodegenerative diseases.
Systematic investigation of ligand substitution effects in cyclophane-based nickel(II) and palladium(II) olefin polymerization catalysts
Popeney, Chris S.,Levins, Chris M.,Guan, Zhibin
experimental part, p. 2432 - 2452 (2011/06/22)
The synthesis of Ni(II) and Pd(II) cyclophane-based α-diimine olefin polymerization catalysts bearing a range of electron-donating or -withdrawing groups is described. Substituent effects were confirmed by measurement of CO infrared stretching frequencies
Selective oxidation of aromatic amines to nitro derivatives using potassium iodide-tert-butyl hydroperoxide catalytic system
Reddy, K. Rajender,Maheswari, C. Uma,Venkateshwar,Kantam, M. Lakshmi
supporting information; experimental part, p. 93 - 96 (2009/08/07)
The direct oxidation of aromatic primary amines to the corresponding nitro compounds selectively in 47-98% yields has been achieved by using potassium iodide as catalyst and tert-butyl hydroperoxide as the external oxidant. The present catalytic system works well for both electron-rich and electron-poor substrates.
